Update on cardiovascular complications in HIV infection.
about
Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIVRecent key advances in human immunodeficiency virus medicine and implications for ChinaSynbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.Impaired distensibility of ascending aorta in patients with HIV infectionImmune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.Clinically significant incidental findings among human immunodeficiency virus-infected men during computed tomography for determination of coronary artery calcium.Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.Effects of tipranavir, darunavir, and ritonavir on platelet function, coagulation, and fibrinolysis in healthy volunteers.Effects of a Low Dose of Fish Oil on Inflammatory Markers of Brazilian HIV-Infected Adults on Antiretroviral Therapy: A Randomized, Parallel, Placebo-Controlled TrialPatterns of cardiovascular disease in a group of HIV-infected adults in Yaoundé, CameroonTelmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot studyDysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adultsPerturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.Effect of Chocolate and Yerba Mate Phenolic Compounds on Inflammatory and Oxidative Biomarkers in HIV/AIDS IndividualsImpact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy.Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.Low levels of endothelial progenitor cells and their association with systemic inflammation and monocyte activation in older HIV-infected men.Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis.Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trialAbstracts of the HIV Drug Therapy in the Americas 8-10 May 2014, Rio de Janeiro, BrazilMetabolic and Cardiovascular Comorbidities Among Clinically Stable HIV Patients on Long-Term ARV Therapy in Five Ambulatory Clinics in Lima-Callao, Peru
P2860
Q33615509-DF74FB49-8C83-4E93-B8B0-132DFDBE3834Q33933502-7856B956-47D0-457C-8E37-7EE3FF422876Q34308383-2A677256-46B2-4961-9A99-A04C1BAC6468Q34356622-DA471172-BC3E-489F-A473-8EF6F647400CQ34412603-69AA8DD2-02B3-4964-86A0-5577612A9129Q34789165-4CBF40BD-6131-4642-B0B8-CCD0A997A4C2Q34911693-67C3523F-5E3B-4067-BA68-7AC965DAD3ECQ35030752-A03841EC-58D5-4540-B4C6-F685D30E7B90Q35861534-123883BA-401D-4740-9130-A83ECF91464AQ35932065-0A5AA752-B1AE-4A35-8097-9ECE1A633650Q36012395-E2780753-C329-4F3E-943A-4C46F1ED92F6Q36338369-B16B410D-75FD-4116-AB5A-3672A5A9C066Q36430090-ED3F419F-8FAB-4CC7-A0D9-1E674D31E4DEQ36697990-47150181-8D44-45F5-915F-E14769128D14Q36842216-AF06350D-1A28-4BBF-88D3-18177B295E45Q36941675-1BF00861-B1F2-4044-87AF-252A391E4E4FQ37077610-70AC32D0-46DD-4FD3-9EEB-6FC4C5F3E42CQ39361501-E9CA0E90-685F-405D-A35A-8572BEE008BBQ42654265-EBBC6B4B-CC32-44A0-B24D-30A58234E61FQ46350318-9D95C3BC-3CC1-4264-92F8-B73474E0D74EQ50130203-75FC4EA7-8884-4BA0-A437-AA6546671A60Q58000817-AB91ABC1-8EB4-42C6-A7DA-3E269A3F3806Q58055043-457BAC01-538A-4090-B0E0-45667FE20BE2Q59137576-5476EEC6-548A-4CF1-91A6-A2B6C0720FC1
P2860
Update on cardiovascular complications in HIV infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on cardiovascular complications in HIV infection.
@en
Update on cardiovascular complications in HIV infection.
@nl
type
label
Update on cardiovascular complications in HIV infection.
@en
Update on cardiovascular complications in HIV infection.
@nl
prefLabel
Update on cardiovascular complications in HIV infection.
@en
Update on cardiovascular complications in HIV infection.
@nl
P1476
Update on cardiovascular complications in HIV infection
@en
P2093
Judith S Currier
P304
P577
2009-07-01T00:00:00Z